Hypermarcas (HYPMY)
(Delayed Data from OTC)
$4.95 USD
-0.24 (-4.62%)
Updated Sep 20, 2024 03:59 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Hypermarcas falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,585 | 1,462 | 1,100 | 793 | 835 |
Cost Of Goods | NA | 539 | 396 | 283 | 306 |
Gross Profit | NA | 922 | 705 | 510 | 529 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 441 | 340 | 254 | 253 |
Income After Depreciation & Amortization | 0 | 481 | 365 | 256 | 275 |
Non-Operating Income | NA | 49 | 23 | 28 | 24 |
Interest Expense | NA | 217 | 82 | 43 | 21 |
Pretax Income | NA | 312 | 305 | 241 | 279 |
Income Taxes | NA | -18 | 5 | -15 | -23 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 330 | 331 | 300 | 256 | 301 |
Extras & Discontinued Operations | 0 | -2 | -53 | -5 | -6 |
Net Income (GAAP) | 330 | 329 | 246 | 251 | 295 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 514 | 389 | 279 | 306 |
Depreciation & Amortization (Cash Flow) | NA | 33 | 25 | 24 | 31 |
Income After Depreciation & Amortization | 0 | 481 | 365 | 256 | 275 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 637.79 | 633.73 | 630.48 | 631.76 | 631.29 |
Diluted EPS Before Non-Recurring Items | 0.52 | 0.52 | 0.47 | 0.41 | 0.48 |
Diluted Net EPS (GAAP) | 0.52 | 0.51 | 0.39 | 0.40 | 0.46 |
Fiscal Year end for Hypermarcas falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 420.00 | 368.97 | NA | 437.96 | 450.68 |
Cost Of Goods | NA | NA | NA | 160.70 | 166.02 |
Gross Profit | NA | NA | NA | 277.26 | 284.66 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 126.56 | 136.36 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 150.70 | 148.30 |
Non-Operating Income | NA | NA | NA | 12.74 | 11.61 |
Interest Expense | NA | NA | NA | 66.29 | 64.59 |
Pretax Income | NA | NA | NA | 97.14 | 95.31 |
Income Taxes | NA | NA | NA | -5.15 | -6.57 |
Minority Interest | NA | NA | NA | -0.03 | 0.18 |
Investment Gains/Losses | NA | NA | NA | 0.00 | 0.00 |
Other Income/Charges | NA | NA | NA | 0.00 | 0.00 |
Income From Cont. Operations | 94.37 | 79.09 | NA | 102.29 | 101.89 |
Extras & Discontinued Operations | 0.13 | -0.53 | NA | -0.04 | -0.10 |
Net Income (GAAP) | 94.50 | 78.56 | NA | 102.28 | 101.61 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 631.39 | 632.72 | NA | 631.99 | 637.86 |
Diluted EPS Before Non-Recurring Items | 0.15 | 0.12 | NA | 0.16 | 0.16 |
Diluted Net EPS (GAAP) | 0.15 | 0.12 | NA | 0.16 | 0.16 |